Skip to main content

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle.

Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases.

Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strategies designed to reverse dysregulation in cancer. Several cancer research studies that utilize epigenetics techniques are currently underway; significant investments are being made to support these researches. The increasing prevalence of cancer will drive epigenetics research focused on this condition, which will drive growth in epigenetics market.

The global epigenetics market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2016, at a CAGR of 13.3%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896

Applications of Epigenetics Market:

# Oncology
# Metabolic Diseases
# Developmental Biology
# Immunology
# Cardiovascular Diseases

Oncology is one of those applications where epigenetics technology is extensively used for deriving therapeutic strategies designed to reverse transcriptional abnormalities inherent to the cancer epigenome. The disruption of epigenetic modifications, such as DNA methylation and histone modification, results in altered gene function or expression and cellular transformation leading cancer. Epigenetics assists in the development of inhibitors of DNA methyltransferases and histone deacetylases (HDACs), which have been found to be clinically effective in cancer treatment, attesting to the value of epigenetic therapies in oncology.

Major Market Developments:

1. In July 2017, Agilent launched AriaDx Real-Time PCR System
2. In June 2017, Illumina launched Extended RAS Panel, a NGS kit
3. In January 2017, Illumina entered into an agreement with Koninklijke Philips (Netherlands) to integrate Ilumina’s sequencing systems with Philips’ IntelliSpace Genomics clinical informatics platform for oncology.

Regional Analysis of Epigenetics Market:

The epigenetics market in Asia-Pacific region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the increasing R&D spending, increasing government initiatives, and rising focus on key market players in the region. Emerging markets such as Brazil, China, and India offer significant growth potential to market players.

Request Sample Report Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=896

This can primarily be attributed to the diversified healthcare market in this region, growing incidence of infectious and chronic disorders, and increasing R&D initiatives targeted at the development of innovative genomic techniques. In addition, developments in research infrastructure, increasing R&D expenditure, low labor cost, and rapid growth in the number of CROs and pharmaceutical industry are encouraging market players to invest in these countries.

Key Players In Epigenetics Market:

The prominent players of this market are Illumina (US), Thermo Fisher (US), Diagenode (Belgium), QIAGEN (Netherlands), Merck Millipore (US), Abcam (UK), Active Motif (US), New England Biolabs (US), Agilent (US), Zymo Research (US), PerkinElmer (US), Bio-Rad (US). 

Comments

Popular posts from this blog

Smoke Evacuation Systems Market: Renewed Growth Opportunities Owing to the Increasing Number of Elective Procedures

  Which are The Key Factors Driving Growth in Smoke Evacuation System Market? Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation system market. How The Smoke Evacuation Industry Will Grow in Coming Years? The surgical smoke evacuation system market is estimated to grow at a CAGR of 6.6% to reach USD 154 million by 2025 from USD 115 million in 2020. Emerging countries and increasing number of elective surgical procedures. Emerging countries (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to players operating in the global smoke evacuation systems market. This can be attributed to the increasing public and private i...

Illumina (US), Thermo Fisher (US), and QIAGEN (Netherlands)—Major Players in the Global Epigenetics Market

The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% from 2017 to 2022. Favorable government funding initiatives for epigenetics research, increasing research activities, decreasing sequencing costs & time, and rising prevalence of cancer are the key factors driving market growth Key players in the global epigenetics market, such as Illumina, Thermo Fisher, Diagenode, Merck Millipore, Abcam, Active Motif, New England Biolabs, Agilent, Zymo Research, and PerkinElmer, are focusing on increasing their presence in the high-growth markets through organic as well as inorganic strategies such as product launches, partnerships, agreements, collaborations, expansions, and acquisitions. http://www.marketsandmarkets.com/ResearchInsight/epigenetics-technologies-market.asp Illumina dominated the global epigenetics market in 2016. The company provides sequencing and array-based solutions for ge...

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...